The financing and organization of medical care for patients with end-stage renal disease in Sweden

Int J Health Care Finance Econ. 2007 Dec;7(4):269-81. doi: 10.1007/s10754-007-9014-y.


The total health care expenditure as a percentage of the gross domestic product in Sweden is 9.2%, and health care is funded by global budgets almost entirely through general taxation. The prevalence rate of end-stage renal disease (ESRD) in Sweden is 756 per million. Fifty-two percent of ESRD patients have a functioning transplant. Almost all ESRD treatment facilities are public. Compared with other Dialysis Outcomes and Practice Patterns Study (DOPPS) countries, the salaries for both nephrologists and professional dialysis unit staff are low. Sweden's high cost per ESRD patient, relative to other DOPPS countries, may be a result of expensive and frequent hospitalizations and aggressive anemia treatment strategies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Delivery of Health Care / economics
  • Delivery of Health Care / organization & administration*
  • Health Care Costs
  • Health Services Research
  • Humans
  • Kidney Failure, Chronic / economics*
  • Kidney Failure, Chronic / epidemiology
  • Kidney Failure, Chronic / therapy*
  • Kidney Transplantation / economics*
  • National Health Programs / economics
  • National Health Programs / organization & administration*
  • Renal Dialysis / economics*
  • Sweden / epidemiology
  • Treatment Outcome